The development and therapeutic application of long-acting injectable antipsychotics (LAIs) represent a significant advancement in the management of psychiatric disorders. In the developmental context, TDM emerges as an indispensable tool, guiding researchers in optimizing pharmacokinetics and ensuring the efficacy and safety of these novel formulations.
No takes yet. Share an insight, caveat, or question.
Christoph U. Correll (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: